Bone & Joint
46 - 60 of
71 Results
Sort Results:
Article:
Xeljanz (ZEL-jans, tofacitinib), a new ORAL treatment for moderate to severe rheumatoid arthritis in adults
September 2014
Article:
fewer red flags when celecoxib (Celebrex) is given to patients with a sulfa allergy
February 2014
Guideline:
2012 American College of Rheumatology Guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia
December 2012